According to an analysis by Natural Blaze, an FDA ban on the mass production of intravenous Vitamin C caused a critical shortage of IV bags. The FDA chose to limit the availability of the IV-C, causing the pharmaceutical industry to halt the production of injectable vitamins and minerals. Doctors then looked to compounding pharmacies to produce it, causing other issues.
After injectable steroids produced by the New England Compounding Center were contaminated with a fungus that caused a deadly outbreak of meningitis, the FDA began to limit compounding pharmacies as well. The reason doctors were looking to compounding pharmacies in the first place, was because of the FDA.
Natural Blaze reports, “…without anyone noticing, and by many indirect means of banning production of the bags or shutting down those doing the production of the bags and the injectable vitamins and minerals, access to IV solutions for innumerable treatments for diseases, have gone into critical shortage.”
Vitamin C And Cancer Treatment
Many alternative cancer therapies rely on intravenous Vitamin C. Dr. Whitaker is the founder of the Whitaker Wellness Institute, one of the largest providers of alternative health therapies in the United States.
He explained, “…vitamin C is a potent antioxidant that has the power to boost immune function, increase resistance to infection, and protect against a wide range of diseases. But there’s an entirely different and largely unknown role of vitamin C, and that is its ability—when administered in very high doses by intravenous (IV) infusions—to kill cancer cells… Best of all—and unlike virtually all conventional chemotherapy drugs that destroy cancer cells—it is selectively toxic. No matter how high the concentration, vitamin C does not harm healthy cells.”
He continued, “The only way to get blood levels of vitamin C to the concentrations required to kill cancer cells is to administer it intravenously. … For example, 10 g of IV vitamin C raises blood levels 25 times higher than the same dose taken orally, and this increases up to 70-fold as doses get larger.”
Does the FDA ban on mass production of intravenous Vitamin C have something to do with halting alternative cancer therapies? If not, why limit the production and availability of such an important medicine?